“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Caris Life Sciences
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
+4
Caris Life Sciences (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia ...
| C-Level 19 | VP - Level77 |
| Director160 | Manager236 |
| Others266 | |
| Structure | Email Format |
|---|---|
| <first>_<last>@ | John_Smith@carislifesciences.com |
| <l><first>@ |
|
| <first>@ | John@carislifesciences.com |
| <first>.<last>@ | John.Smith@carislifesciences.com |
| <first><last>@ | JohnSmith@carislifesciences.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Account Payable | Irving, TX | revolution, communication, internet, continuous improvement, e, testing, audit, compliance, payment, epm, sql, troubleshooting, access management, share, change control, customer service, bi, financial |
| Account Payable | New York, United States | revolution, communication, internet, e, compliance, assessment, billing, workflow, profiling |
| Account Payable | North Carolina, United States | revolution, compliance, communication |
| Account Payable | Phoenix, AZ | basic, revolution, communication, continuous improvement, data center, performance reporting, testing, audit, operating procedures, compliance, corrective action, fax, troubleshooting, windows, macos, customer service, accreditation, operations |
| Account Payable | United States | revolution, communication, internet, root cause analysis, testing, compliance, billing, rest, profiling |
Caris Life Sciences looking to hire in Account Payable in Florida, United States
Caris Life Sciences looking to hire in Account Payable in Delaware, United States
Caris Life Sciences looking to hire in Account Payable in Illinois, United States
Amazon connect
Atlassian jira
Burp suite
Cmms
Cassandra
Agile
Application security
Ci/cd
Devops
Infrastructure management
At Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreAt Caris, we understand that cancer is an ugly worda word no one wants to hear, but one that conn...
View MoreThe stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public offering at $21 per share and
Read MoreCaris Life Sciences, Inc. (CAI) has received a new Buy rating, initiated by TD Cowen analyst, Daniel Brennan. Daniel Brennan has given his Buy rating due to
Read MoreCaris Life Sciences, which offers an AI-powered molecular diagnostics platform focused on oncology, raised $494 million by offering 23.
Read MoreCaris Life Sciences Inc. raised $494 million in a US initial public offering, pricing 23.5 million shares at $21 each, above the top of its marketed range.
Read MoreCaris Life Sciences (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy...
Biotechnology,molecular profiling,genomics,personalized medicine,diagnostics,theranostics,panomics,precision medicine,and comprehensive genomic profiling
Caris life sciences operates in the Biotechnology research industry.
Caris life sciences's revenue is $140.00m
Caris life sciences has 1001 - 5000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.